IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium
May 19, 2023 09:15 ET
|
IR-Med, Inc.
A 94.7% accuracy in identifying Stage 1 pressure injuries was achieved in a proof-of-concept device upon which PressureSafe is basedCompany to exhibit and demo its “sense the invisible” handheld...
IR-Med Announces Dr. David Dalton as Advisory Board member
November 16, 2022 09:32 ET
|
IR-Med, Inc.
Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) --...
IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device
August 30, 2022 09:15 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 30, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company that is developing non-invasive, real-time detection devices...
IR-Med files Provisional Patent Application Covering Additional Features of its PressureSafe Device for Early Detection of Pressure Injuries
August 12, 2022 08:34 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative medical device company, developing non-invasive, real-time detection devices that utilize...
IR-Med To Initiate Useability Study of its PressureSafe Device
June 23, 2022 09:15 ET
|
IR-Med, Inc.
Rosh Pinna, Israel, June 23, 2022 (GLOBE NEWSWIRE) -- (“IR-MED or the “Company”) (OTCQB:IRME), an innovative development stage medical device company that utilizes Infra-Red light spectroscopy (IR)...